Demographic, clinical symptoms, and infusion reaction
data were recorded from the patients' charts.
patients who experienced their first severe infusion reaction
Stop infusion if a severe infusion reaction
These fatalities were associated with an infusion reaction
symptom complex that included hypoxia, pulmonary infiltrates, acute respiratory distress syndrome, myocardial infarction, ventricular fibrillation, or cardiogenic shock.
ProStorm[TM] is designed specifically to indicate when a cytokine storm first infusion reaction
may be a risk for a drug.
During an infusion reaction
, early intervention may prevent serious side effects and death.
Monitor patients closely for signs and symptoms of an infusion reaction
during and for at least four hours following completion of each Unituxin infusion
Antibody concentrations at or above the cutoff increased the relative risk of an infusion reaction
by a factor of 2.
If a severe infusion reaction
occurs, discontinue infusion and institute treatment as needed.
Caution must be exercised with every ERBITUX infusion, as there were patients who experienced their first severe infusion reaction
during later infusions
Post-Hoc Analyses Examining HRQOL, Tophus Reduction and Infusion Reaction
Mitigation Presented at the 2012 ACR/ARHP Annual Meeting
were managed with pre-medication or by slowing infusion rate.